Novo’s next-gen obesity drug misses expectations in closely watched trial Summary: A combination drug called cagrisema helped spur significant weight loss, but missed the bar set by executives, causing shares to fall sharply. Click to see the full article Merck calls quits on two immunotherapies for cancer Summary: The company is scrapping two drugs aimed […]